Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $402.94M.
ENTERPRISE VALUE (EV)
$402.94M
Contineum Therapeutics, Inc.
Market Cap
$478.54M
Enterprise Value (EV)
$402.94M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $478.54M | $402.94M |
| Arvinas, Inc. (ARVN)vs › | $481.33M | $395.23M |
| Cerus Corporation (CERS)vs › | $471.57M | $530.39M |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | $270.40M |
| NRC Health (NRC)vs › | $468.31M | $555.01M |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | $794.37M |
| Evolus, Inc. (EOLS)vs › | $491.93M | $611.57M |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | $448.75M |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | $420.71M |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | $517.54M |
Market Cap
$478.54M
Total Debt
$0.00
Cash
$75.60M
Enterprise Value
$402.94M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
